๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX ยท Real-Time Price ยท USD
155.39
-1.20 (-0.77%)
Nov 20, 2026, 10:11 AM EST - Market open

Neurocrine Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3,7022,8612,3551,8871,4891,134
Revenue Growth
37.98%21.45%24.81%26.76%31.34%8.38%
Gross Profit
2,3941,7931,5901,2821,002791.1
Operating Income
985.5636.5597394.8249207.8
Net Income
702.5478.6341.3249.7154.589.6
Earnings Per Share
6.734.673.292.471.560.92
EPS Growth
60.66%41.95%33.20%58.33%69.56%-77.89%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
INGREZZA
2,8322,5142,3141,8361,4281,082
CRENESSITY
683301.21.7---
ONGENTYS and Other Product
-1915.424.613.18.2
Royalties
--18.621.222.322.3
Collaboration and Other
--6.15.35.56.1
Revenue (Total)
3,7022,8612,3551,8871,4891,134

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
737.91,4801,0761,032989.3711.3
Total Debt
451.8471.3455.1428.4262.9440.4
Net Cash (Debt)
286.11,009621603.2726.4270.9
Net Cash Growth
-54.95%62.50%2.95%-16.96%168.14%-30.31%
Net Cash Per Share
2.759.845.995.977.342.77

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,066782.7595.4389.9339.4256.5
Capital Expenditures
-26.1-34-38.2-28.3-16.5-23.4
Free Cash Flow
1,040748.7557.2361.6322.9233.1
Free Cash Flow Growth
75.30%34.37%54.09%11.98%38.52%7.12%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
64.67%62.67%67.52%67.96%67.29%69.79%
Operating Margin
26.62%22.25%25.35%20.92%16.73%18.33%
Pretax Margin
25.18%24.66%20.63%17.60%14.37%8.95%
Profit Margin
18.98%16.73%14.49%13.23%10.38%7.90%
FCF Margin
28.09%26.17%23.66%19.16%21.69%20.57%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
23.0729.5540.4951.8574.3290.18
Forward PE
13.0515.8718.1521.3422.5324.55
P/FCF Ratio
15.2418.8924.8035.8035.5634.66
PS Ratio
4.284.945.876.867.717.13